Program Process & Timeline

The MassCONNECT process involves a two-month mentorship where industry experts guide entrepreneurs as they seek to develop business plans, launch companies, and raise capital. MassCONNECT mentors evaluate and provide feedback on commercial feasibility; identify strengths, weaknesses, opportunities, and threats; and team up to furnish industry-specific business advice for innovative ideas in therapeutics, diagnostics, medical devices, and digital health. Entrepreneurs gain invaluable advice and coaching on defining their value proposition, developing pitches, and building professional networks.

In addition to entrepreneurs and industry mentors, the MassCONNECT program relies on MBA students with life sciences knowledge or interest to serve as project managers for a MassCONNECT team. For MBAs, MassCONNECT offers invaluable experience, VIP connections, and the potential opportunity for course credit.

Applications for entrepreneurs and mentors are considered on a rolling basis.

MassCONNECT partners and supporters include LabCentral, Harvard Medical School, Harvard iLab, MassChallenge, Tufts Medical Center, Tufts University, Boston Children’s Hospital, Brigham and Women’s iHub, North Shore Innoventures, Massachusetts Biomedical Initiatives, MTTC, Platform, MDG, UMass, and WPI.

For more information on all of our MassCONNECT programs, Please contact Steve Powell.

Entrepreneur Application

There is no official application form for MassCONNECT. The MassBio team will meet with entrepreneurs to learn more about their technologies and share more details on the MassCONNECT program. All qualified applicants will be evaluated based on mutual fit between the entrepreneur and the program.

Technology Showcase

Chosen entrepreneurs will pitch their ideas to a group of mentors and articulate the areas with which they need help at an initial Technology Showcase. MassBio will then match each entrepreneur with a team of five to seven mentors who are best qualified to provide targeted advice, connections, and other resources.

Mentoring Team Meetings

Once matched, entrepreneurs meet with their mentoring teams in focused, one-hour sessions that are held in-person each week for eight weeks. MassBio coordinates the team meetings and hosts them at the MassBio offices.

Final Presentation

Armed with business plan pitch decks and a refined strategy, entrepreneurs pitch to a large audience of industry mentors and other members of the life sciences startup community.

2021 Premier Supporter Sponsors

2020 Participants









  • Step Up IC / Alchemy CGI
  • Watershed Informatics

Meet the Mentors

MassCONNECT mentors provide entrepreneurs with legal, business, and scientific expertise.

For seasoned life sciences industry professionals, becoming a MassCONNECT mentor provides the chance to give back, build relationships with up-and-coming entrepreneurs and other mentors, and access the region’s most exciting opportunities. If you are interested in learning more or getting involved, please contact Steve Powell.

Meet the mentors
NameCompany Position 
Tatyana  Abyzov Shire Due Diligence Lead 
Chris AdamsCydan Development CEO
Mehdi AghdaeeQuant Life SciencesCEO
Faraz AliTenaya Theapeutics CEO
Christopher Allen TakedaHead Counsel, US Litigation and Investigations 
Richard Anders Mass Medical AngelsFounder, Managing Director 
Django AndrewsSarepta Therapeutics Senior Patent Counsel 
Donald ApruzzeseAtentiv LLCChief Comercial Officer 
Bill Asher MassVentures Member Board of Directors 
John BaileyBoston Startup CFO CFO
Farnaz BakshiTufts UniversityAsstistant Director
Alan Barber Prestar Group Principal 
Josh  Barlow Haug Partners LLPPartner 
Mark BarrettFrazier Healthcare Partners Entrepreneur-in-Residence (VC)
Glenn BatchelderKantum BioChairman 
Maria BeconiQuellTxCSO
Milka BedikianIndependent 
Kees BeenLysosomal Therapeutics, Inc. President and CEO
Yaniv BejeranoExcite Healhcare Consulting President and CEO
Nils  BergenhemAstraZeneca Director, Strategy & Externalization, CVMD iMed 
Ed BergerLarchmont Strategic AdvisorsPrincipal 
Charlie BlumAmathus Therapeutics Senior Director of Medicinal Chemistry 
Frank BorrielloAlloplex Biotherapeutics, Inc. President and CEO
Michael BossCenter for Integration of Science and Industry (Bentley University) Executive-in-Residence 
Melissa Bradford-KlugKeryx PharmaCBO
Diana BrassardTakedaDirector 
Robert BratzlerMansitee Partners Managing Director and Co-founder 
Scott BrownZoetisExternal Innovation
Andrea (Andi) BruellIndependent ConsultantIndependent Consultant 
Kristen  Buteau Choate, Hall & Stewart LLPPatent Attorney 
Jay  CahillPepper Hamilton LLPIntellectual Property Attorney 
Fred  Callori Xontogenv SVP Corporate Development 
Miguel CamargoUCB New MedicinesDirector, Innovation Super Networks
Walter CarneyWalt Carney Biomarkers Consulting, LLCFounder & CEO
Jennifer CarterN of OneChief Medical Officer, Founder and President 
Jennifer ChadwickBioAnalytixVice President of Biologic Development
Anirban ChatterjeeElevate BioSenior Director 
Pravin ChaturvediOceanyx Pharmaceuuticals Co-founder & Chief Executive Officer 
Ying ChenWilson Sonsini Goodwin & RosatiAssociate
Fangli Chen Proskauer Rose LLP 
Monica ChengBoehringer IngelheimDeputy Head, Business Development & Licensing, Cardiometabolic Diseases
Thomas ColletPhrixus Pharamaceuticals, Inc. President, CEO and Director 
Gilles CottierLonza Head of Lonza Bioscience
Peter CovitzBiogenSenior Director, Medical Evidence, Research and Innovation 
Geoff Cox Independent ConsultantIndependent Consultant 
Frank DavidPharmagellanFounder and Managing Director
Nate DavisRA Capital Management, LLC Jr Associate 
Christopher De SouzaBroadway Ventures Director 
Amy DeClouxNutter McClennen & Fish LLPOf Counsel
Tom DefayAlexion Pharmaceuticals, Inc. Senior Director, R&D Strategy and Alliance Management 
John DellapaMintz Levin Member 
John DelyaniTmunity Therapeutics Incorporated VP, Corporate and Business Development 
Chris  DennGoodwin Procter Partner 
Amit DeshpandeEMD Serono, Inc. Associate Director, Biomarkers, Immunooncology Translational Innovation Program (TIP)
Sheila DewittDeuteRxPresident and CEO
Rakhshita DharRocheBusiness Development/Innovation Partnering 
Tony DiLeoChiamanti Principal 
Greg DombalHalloran Consulting Group, Inc. COO
Angelos DovletoglouOrigin BioSciences Senior Vice President of Technical Operations 
Nan DoyleTrillium Principal 
Heather DuffyCreative Innovation ConsultingFounder
Bill Edelman Paragonix Technologies Chairman of the Board 
Ryan EgelandCardiovascular Systems, Inc. EVP
James EllisNocion TherapeuticsCSO
Tom Engellener NelsonMullins Riley & Scarborough Partner 
Greg Erman EmpirMed, Inc. President and CEO
Eric EvansMass Medical AngelsExecutive Committee
Diala  Ezzeddine Xios Therapeutics, Inc. CEO
Martha  FarmerNorth Shore InnoVentures Co-founder and Board Member 
Bonnie FendrockCyta TherapeuticsCo-founder and Chief Executive Officer 
Brian FentonTranslate BioChief Business Officer 
Toby FergusonBiogenSenior Medical Director 
Clare FisherKaleido Biosciences CBO
Michelle  FloresSunovion Pharmaceuticals, Inc. Assistant General Counsel, Litigation & Business Development 
Roger  FrechetteNew England PharmAssociates, LLCCo-founder & Partner
Simon FrickerBiopharma Independent Consultant
Brian  GallagherAbingworthPartner
Manjori GangulySanofiSenior Scientist – Pharmaceutical drug development
Junjun GaoBoehringer IngelheimSenior Associate Director 
Han GaoWilson Sonsini Goodwin & RosatiAssociate
Jason  Gardner Magenta Therapeutics CEO, President, and Co-founder
Shahin GharakhanianShahin Gharakhanian MD Consulting LLCPrincipal and Founder, Executive Consultant/ Chief Medical Officer 
Richard  Gill ActiveCyte Holdings President and CEO
John GlasspoolShire Head of CSCO
Brain  Goldstein Choate, Hall & Stewart LLPPartner 
Leonid GorelikFortress BiotechVice President of Drug Discovery
Robert GottliebRMG Associates, LLCPrincipal 
Gena  GoughClinical InkProject Director, ePRO and Engagement 
Vikas GoyalSR OneAssociate
Philip GrahamSojournix Inc. SVP Development 
John GrantIntellia Therapeutics, Inc. Director of Business Development 
Luba GreenwoodGoogleStrategic Business Development and Corporate Ventures 
Brenda  Grimes Eli LillyPublication Coordinator Global Scientific Communications 
Stephanie HallamAdaptive Biotechnologies Corp.VP and Clinical Laboratory Director 
John HallinanMassBioCBO
Laurie  Halloran Halloran Consulting Group, Inc. President 
Jeremy HalpernNutter McClennen & Fish LLPPartner
Kouki  Harasaki Andreessen Horowitz Partner 
David HarburgerWilson Sonsini Goodwin & RosatiAssociate Patent Attorney
Maia  Harris Pepper Hamilton LLPPartner 
Paul HartungMedical Development Group BostonBoard Member
Joubin HatamzadehGreentown Labs VP of Operations 
John HennessyAstraZeneca Neuro Head of Business Operations, R&D
Steve  HerbertFormerly with Cytel 
Arthur HillerHiller Life Sciences StrategiesInterim CEO & Business Advisor
George Hillman  
John HoCharles River LabsChief Strategy Officer 
Richard HowellAerian Pharma Consulting Director of Business Solutions
Shayne  HuffNixon Peabody LLP Senior Associate  
Irena IvanovskaCeldara MedicalDirector
Eva  JackMersana Therapeutics CBO
Matthew JarpeRegancy Pharmaceuticals VP of R&D
Andrew JayFormerly with Siemens Medical Ventures 
Rick  Jones BioAdvance Partner 
Joel KahnJAK Health ConsultingPrincipal
Rosanna KapellerGoogle VenturesEIR
Tariq Kassum  
James  KasuboskiBoehringer Ingelheim Venture FundSenior Director 
John KethchumBonneyview Consulting , LLCFounder and Principal 
Minji KimJounce Therapeutics, Inc. Head, BD & Alliance Management 
Jenn King Intellia Therapeutics, Inc. SVP, Business Development 
Jeffrey KiplingerIndependent ConsultantIndependent Consultant
Alan KuglerCoastal Pharma GroupCSO
Anjali KumarFormerly with Shire/Takeda Due Diligence Lead – Corporate Development
Chuck KunschAbbvie VenturesSenior Director
Stephanie KweiMass Medical AngelsMember 
Sushmita LahiriBoehringer IngelheimExternal Innovation Research Beyond Borders 
Derek  LeeAthyrium Capital Management, LLPSenior Advisor 
Reid  LeonardTwentyeight-Seven Therapeutics Consultant 
Mark LeuchtenbergerBrooklyn ImmunoTherapeutics Interim President and CEO
Nancy  Levy Biohealth Management, LLCManaging Partner 
Bob  Licht Choate, Hall & Stewart LLPPartner 
Nimita LimayeApplied Technol Solns Inc (ApTSi) 
Debbie LinBoehringer Ingelheim Venture FundExecutive Director 
Clark LinWilson Sonsini Goodwin & RosatiAssociate
Steve  London Pepper Hamilton LLPPartner 
Rick Lundberg7S BioVenturesPresident 
John LynchCYTO Consulting  
Karla MacDonaldIpsen VP, Communications and Patient Advocacy
Geoff  MacKayAVROBIOFounder, President and CEO
Lynn MallettAnthos Therapeutics VP and Head of Finance 
Raj ManchandaBill and Melinda Gates Medical Research InstituteInovation Portfolio Leader 
Neal  MantickMantick Life Sciences Consulting, LLCFounding Manger 
Katya MantrovaIndependent Consultant 
Albine MartinBioHealth InnovationEIR
Michael Maurer CelgeneVP, Global Marketing – Inflammation and Immunology
Kevin MayoPTC Therapeutics, Inc.Global Head Market Access, New Products
Jack  McCullough The CFO Leadership Council President 
Philip McGurkPfizerBusiness Development Lead, Inflammation and Immunology Business Unit 
John McKeagueWilson Sonsini Goodwin & RosatiOf Counsel
Danielle McLaughlin Solomon & Cramer LLPCounsel 
Thomas McMurryBoston University Office of Technology Development Director, Life Sciences Business Development 
Catherine MesnerIndependent Consultant Independent Pharmaceutical Consultant 
Colin MinchomIndependent ConsultantIndependent Consultant 
Erin MistrySyneos HealthSenior Managing Director, Head of Value, Access and HOER
Jay  MohrLocust Walk, LLCPartner Emeritus and Founding Member
Reza Mollaaghababa Pepper Hamilton LLPPartner
David MollerSigilon Therapeutics, Inc. CSO
Joep MuijersPureTech HealthCFO
Inhua Muijrers-ChenRipplet HealthCo-founder
Joseph F. MurphyimmunePCS LLC Founder and President
Adam Muzikant Flexion TherapeuticsSVP, Business Development 
Imran NasrullahBoehringer Ingelheim Director, Strategic Partnering, BD&L
Wendy NelsonLeadingBioTech CEO and President, Life Sciences, Boston 
Gordon NgAbbVie Inc.  Search and Evaluation, Corporate Strategy Office 
Vinit NijhawanMassachusetts Technology Transfer Center Interim Executive Director 
Corrinne  NoyesLyra Therapeutics 
Cheryl NutterHuLow Medical 
Kenneth  O’HaraKPMGManaging Director 
Walter OlesiakRemiges VenturesPartner
Doug  Onsi Leap TherapeuticsCFO 
Matthew O’RourkeInvest in Northern IrelandAssociate Business Development Director 
Nandan PadukoneNeuroBio Pharmaceuticals, Inc. SVP, Business Development 
Rekha PaleyandaServierDirector 
Robert PerniJMD Pharma Creativity LLCFounder and Principal 
Parika PetaipimolPandion Therapeutics Associate Director, Program Management 
David PollardSartorius Stedim Norh America, Inc. Head of New Materials & Components, Corporate Research, Sartorius Stedim 
Drew PrigodichPfizerSenior Director Global R&D Strategy 
Brad  ProsekAll Terrain BioPartners LLCPresident 
Prakash PurohitTakeda Corporate Development, Alliance Mangement Lead 
Imran Qidwai Intel Corporation Program Manager 
Gail RadcliffeRadcliffe Consulting, Inc. President, Independent Consultant 
Mark Ralph Boehringer Ingelheim Executive Director, Global Head, Contracts and Alliance Management 
Chandra RamanathanBayer VP and Head, East Coast Innovation Center 
Julia Rashba- StepPhosphorex 
John  Rearick Choate, Hall & Stewart LLPPatent Attorney 
Kiran  ReddyBlackstone Life Sciences 
John ReillyApic Bio, Inc. Co-founder/President and CEO
Paul  Rennert Aleta Biotherapeutics President & CSO
Charlie  Richard Oxyrane UKMember Board of Directors 
Tim RichardsSeventh Sense BiosystemsCOO
John RippleExonics Therapeutics CEO
Andrew  Sage KPMGPartner 
Rob  Sahr Choate, Hall & Stewart LLPPatent Attorney 
Uciane ScarlettAtlas Venture Associate 
Alison SchecterSanofi Genzyme 
Leora SchiffAltius Strategy ConsultingPrincipal 
Daniel Schöner Perkin Elmer, Inc. Senior Director Diagnostics R&D
Margrit SchwarzGenevantCSO and Head of R&D
Joachim SeidelMedsight LLC Principal 
James  ShanahanSynDevRx, Inc. Co-founder and CBO
Fei ShenBoehringer IngelheimSenior Associate Director, Immunology and Respiratory Therapeutic Area 
Mansi ShindeHealth Advances Consultant 
Leslie ShinobuBiogen 
Lisa  ShmerlingDecibel TherapeuticsVice President and Legal 
Bill  SkillmanVelico Medical, Inc. President and CEO
Kevin SlatkavitzThinkQuality, LLC President and Founder 
Craig SorensenIndependent Pharma Consultant Independent Consultant 
John SorvilloReForm Biologics Executive Officer 
Avi SpierNovartis Director of BD&L in NIBR, Search and Evaluation 
Jeremy SpringhornSyros Pharmaceuticals CBO
Arto  Suren KPMGManaging Director – Valuation Services 
John TagliamonteMassBioEntrepreneur in Residence
Brad Tait Frequency Therapeutics VP Medicinal and Proces Chemistry 
Maude TessierKyn Therapeutics VP Business Development 
Tunc Toker Galen Therapeutics Head of Strategy 
Dominic TongDMM&RS CEO and Principal 
Stephan ToutainAnavex  Life Sciences SVP Operations 
Christopher TsuIndependent Consultant 
Stephen TurkowiakTCR2 Therapeutics, Inc. Vice President, Finance 
Katherine Turner   
Arthur Tzianabos Homology Medicines, Inc. President & CEO
Ramani Varanasi X-Biotix Therapeutics, Inc. Co-founder, President and CEO
Ajay VermaPrecision for Medicine, Llama Therapeutics, Annexon Biosciences Scientific Advisor 
John ViliesisL3T – Space & Sensors Division Director of Program Controls 
Chris Vlahos Ipsen Global Head, Rare Disease External Innovation 
Chris Von Seggern ClearView Healthcare Partners Partner 
Alex Waldron Pear Therapeutics Chief Strategy Officer and Chief Commercial Officer 
Bob Wassman Life Designs Ventures Principal, CEO and CMO 
Nigel WatersBlack Diamond Therapeutics Vice President, Preclinical Development 
Alan WatsonSSRP AssociatesPrincipal
Mike WebbIntrinsicBio Life Sciences Consulting LLC Principal 
Howard Weisman Sofregen Inc. Executive Chairman
Charles WilsonUnum Therapeutics President and CEO
Larry Wittenberg Goodwin Procter LLP Partner, Co-Chair of Life Sciences 
Adam WolfbergOvia Health CMO
Michael WyandOxeia Biopharmaceuticals, Inc. CEO
Nader Yaghoubi PathMaker Neurosystems, Inc. Co-founder and CEO
Shinjin YueCorTechs Labs Channel and Alliance Management 
Sue ZeltJohnson & Johnson, Global Public Health Global Market Access Director 

MassCONNECT Testimonials

See what MassCONNECT participants have to say about their experiences in the MassBio entrepreneur mentorship program.

“Our faculty have great ideas and the MassCONNECT program provides the essential real world flavor, advice, and connections to catalyze and transform those ideas into business plans, commercial products, and companies.”

Isaac (Zak) Kohane, MD, PhD, Lawrence J. Henderson Professor of Pediatrics, Boston Children’s Hospital Informatics

“MassCONNECT’s mentoring program for our clinician entrepreneurs is the top mentoring program in a crowded sea of programs vying for innovation. What makes MassCONNECT unique is the unparalleled investment of time from top talent whose unique insight unlocks commercial value for impactful results. All of Tufts Medical Center teams have emerged stronger both financially and strategically as a result of our MassCONNECT experience.”

Nancy Wetherbee, Director, ORBIT, Tufts Medical Center

“We have put together a diverse and solid advisory team in large part due to MassCONNECT. We have participated in a number of accelerator and incubator programs, and MassCONNECT was invaluable. We particularly liked the ability to have “focus group” sessions on specific questions-this seemed to work well for both us and our mentors. Several of them have continued to help us in meaningful ways.”

Michio Painter, Co-Founder, Blue Therapeutics

“MassCONNECT was a very valuable program for our team. It connected us to a number of industry advisors who we remain in touch with to this day. These are individuals who provided critical formative thought in the early days of VitaThreads when we were still working to focus our vision of what the company could and should be. Transitioning from a unique and exciting academic technology into a usable commercial product with accompanying strategy and logistics train to bring it to market is a non-trivial exercise and not one done in a vacuum. The MassCONNECT program provided key learning opportunities and outstanding mentors in helping to ease this transition for VitaThreads.”

Adam Collette, CEO, VitaThreads